146 related articles for article (PubMed ID: 15200288)
1. Quantification of the pathological changes in the temporal lobe of patients with a novel neurofilamentopathy: neurofilament inclusion disease (NID).
Cairns NJ; Armstrong RA
Clin Neuropathol; 2004; 23(3):107-12. PubMed ID: 15200288
[TBL] [Abstract][Full Text] [Related]
2. Laminar degeneration of the frontal and temporal cortex in neuronal intermediate filament inclusion disease (NIFID): a study original using alpha-internexin immunohistochemistry.
Armstrong RA; Cairns NJ
Clin Neuropathol; 2006; 25(5):209-15. PubMed ID: 17007442
[TBL] [Abstract][Full Text] [Related]
3. Temporal lobe pathology of human patients with neurofilament inclusion disease.
Cairns NJ; Jaros E; Perry RH; Armstrong RA
Neurosci Lett; 2004 Jan; 354(3):245-7. PubMed ID: 14700742
[TBL] [Abstract][Full Text] [Related]
4. Spatial correlations between the neuronal inclusions, swollen achromatic neurons, and glial cells in neuronal intermediate filament inclusion disease (NIFID).
Cairns NJ; Armstrong RA
J Neural Transm (Vienna); 2005 Apr; 112(4):473-80. PubMed ID: 15375676
[TBL] [Abstract][Full Text] [Related]
5. A quantitative study of the pathological lesions in the neocortex and hippocampus of twelve patients with corticobasal degeneration.
Armstrong RA; Cairns NJ; Lantos PL
Exp Neurol; 2000 Jun; 163(2):348-56. PubMed ID: 10833308
[TBL] [Abstract][Full Text] [Related]
6. Multiple system atrophy: laminar distribution of the pathological changes in frontal and temporal neocortex--a study in ten patients.
Armstrong RA; Lantos PL; Cairns NJ
Clin Neuropathol; 2005; 24(5):230-5. PubMed ID: 16167547
[TBL] [Abstract][Full Text] [Related]
7. Neuronal and glial tau pathology in early frontotemporal lobar degeneration-tau, Pick's disease subtype.
Mimuro M; Yoshida M; Miyao S; Harada T; Ishiguro K; Hashizume Y
J Neurol Sci; 2010 Mar; 290(1-2):177-82. PubMed ID: 20022024
[TBL] [Abstract][Full Text] [Related]
8. Laminar distribution of the pathological changes in frontal and temporal cortex in 8 patients with progressive supranuclear palsy.
Armstrong RA; Cairns NJ
Clin Neuropathol; 2009; 28(5):350-7. PubMed ID: 19788050
[TBL] [Abstract][Full Text] [Related]
9. Spatial patterns of the pathological changes in the temporal lobe of patients with neuronal intermediate filament inclusion disease.
Cairns NJ; Armstrong RA
Neuropathology; 2005 Dec; 25(4):298-303. PubMed ID: 16382778
[TBL] [Abstract][Full Text] [Related]
10. Neuropathological changes in ten cases of neuronal intermediate filament inclusion disease (NIFID): a study using alpha-internexin immunohistochemistry and principal components analysis (PCA).
Armstrong RA; Kerty E; Skullerud K; Cairns NJ
J Neural Transm (Vienna); 2006 Sep; 113(9):1207-15. PubMed ID: 16362634
[TBL] [Abstract][Full Text] [Related]
11. KP1 expression of ghost Pick bodies, amyloid P-positive astrocytes and selective nigral degeneration in early onset Picks disease.
Kobayashi K; Hayashi M; Fukutani Y; Miyazu K; Shiozawa M; Muramori F; Aoki T; Koshino Y
Clin Neuropathol; 1999; 18(5):240-9. PubMed ID: 10505433
[TBL] [Abstract][Full Text] [Related]
12. Frontotemporal lobar degeneration and ubiquitin immunohistochemistry.
Josephs KA; Holton JL; Rossor MN; Godbolt AK; Ozawa T; Strand K; Khan N; Al-Sarraj S; Revesz T
Neuropathol Appl Neurobiol; 2004 Aug; 30(4):369-73. PubMed ID: 15305982
[TBL] [Abstract][Full Text] [Related]
13. Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation.
Shi J; Shaw CL; Du Plessis D; Richardson AM; Bailey KL; Julien C; Stopford C; Thompson J; Varma A; Craufurd D; Tian J; Pickering-Brown S; Neary D; Snowden JS; Mann DM
Acta Neuropathol; 2005 Nov; 110(5):501-12. PubMed ID: 16222525
[TBL] [Abstract][Full Text] [Related]
14. Clustering of Pick bodies in the dentate gyrus in Pick's disease.
Armstrong RA; Cairns NJ; Lantos PL
Neuropathology; 2000 Sep; 20(3):170-5. PubMed ID: 11132931
[TBL] [Abstract][Full Text] [Related]
15. Extending the clinicopathological spectrum of neurofilament inclusion disease.
Josephs KA; Uchikado H; McComb RD; Bashir R; Wszolek Z; Swanson J; Matsumoto J; Shaw G; Dickson DW
Acta Neuropathol; 2005 Apr; 109(4):427-32. PubMed ID: 15754170
[TBL] [Abstract][Full Text] [Related]
16. Influences of intranuclear inclusion on nuclear size - morphometric study on pontine neurons of neuronal intranuclear inclusion disease cases.
Uchihara T; Tanaka J; Funata N; Arai K; Hattori T
Acta Neuropathol; 2003 Feb; 105(2):103-8. PubMed ID: 12536220
[TBL] [Abstract][Full Text] [Related]
17. Densities of parvalbumin-immunoreactive neurons in non-malformed hippocampal sclerosis-temporal neocortex and in cortical dysplasias.
Zamecnik J; Krsek P; Druga R; Marusic P; Benes V; Tichy M; Komarek V
Brain Res Bull; 2006 Feb; 68(6):474-81. PubMed ID: 16459206
[TBL] [Abstract][Full Text] [Related]
18. Cystatin C expression is associated with granule cell dispersion in epilepsy.
Pirttilä TJ; Manninen A; Jutila L; Nissinen J; Kälviäinen R; Vapalahti M; Immonen A; Paljärvi L; Karkola K; Alafuzoff I; Mervaala E; Pitkänen A
Ann Neurol; 2005 Aug; 58(2):211-23. PubMed ID: 16049933
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
Chalmers KA; Love S
J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
[TBL] [Abstract][Full Text] [Related]
20. The spectrum and severity of FUS-immunoreactive inclusions in the frontal and temporal lobes of ten cases of neuronal intermediate filament inclusion disease.
Armstrong RA; Gearing M; Bigio EH; Cruz-Sanchez FF; Duyckaerts C; Mackenzie IR; Perry RH; Skullerud K; Yokoo H; Cairns NJ
Acta Neuropathol; 2011 Feb; 121(2):219-28. PubMed ID: 20886222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
